A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias. Furthermore, the ...
New pharmacological agent, SS-68 demonstrates promising results in the prevention of a wide range of heart rhythm disorders and conditions of reduced blood flow to the heart caused by clogged arteries ...
Rhythm will use Camurus' drug delivery technology, FluidCrystal ®, to formulate its once-weekly obesity drug candidate, setmelanotide (RM-493), then develop, manufacture, and commercialize the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback